For patients managing chronic conditions, a COVID-19 infection can create challenges that last beyond the acute illness itself. It may worsen existing health problems and make it harder to return to a normal routine.
That is why timely treatment matters. Early antiviral treatment can help reduce the risk of severe illness and serious complications for people at higher risk.
AMWA Executive Director Dr. Eliza Chin authored this recent blog for the Respiratory Antiviral Alliance co-founded by AMWA.